EI
GLSI icon

EAM Investors’s Greenwich LifeSciences GLSI Stock Holding History

EAM Investors’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$515K Buy
+21,430
New +$559K 0.06% 263

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

EAM Investors's GLSI Position: Q1 2026 in Review

EAM Investors opened a new position in Greenwich LifeSciences (GLSI) in Q1 2026: 21,430 shares worth $515K. The stake represents 0.06% of the portfolio and ranks #263 among its holdings.

64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • EAM Investors held 21,430 shares of Greenwich LifeSciences worth $515K as of Q1 2026.
  • Greenwich LifeSciences was a new EAM Investors position in Q1 2026.
  • Greenwich LifeSciences made up 0.06% of EAM Investors's portfolio in Q1 2026, its #263 holding.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.